Panagora Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-226,098
| Closed | -$2.53M | – | 2430 |
|
|
2017
Q3 | $2.53M | Sell |
226,098
-102,690
| -31% | -$1.15M | 0.01% | 774 |
|
|
2017
Q2 | $3.62M | Buy |
328,788
+68,966
| +27% | +$759K | 0.01% | 666 |
|
|
2017
Q1 | $2.55M | Buy |
259,822
+70,502
| +37% | +$691K | 0.01% | 788 |
|
|
2016
Q4 | $2.05M | Sell |
189,320
-96,513
| -34% | -$1.04M | 0.01% | 895 |
|
|
2016
Q3 | $2.93M | Buy |
285,833
+135,322
| +90% | +$1.39M | 0.01% | 739 |
|
|
2016
Q2 | $1.97M | Sell |
150,511
-12,638
| -8% | -$165K | 0.01% | 874 |
|
|
2016
Q1 | $1.8M | Buy |
163,149
+5,468
| +3% | +$60.2K | 0.01% | 909 |
|
|
2015
Q4 | $1.45M | Buy |
157,681
+35,291
| +29% | +$325K | 0.01% | 924 |
|
|
2015
Q3 | $849K | Buy |
122,390
+28,314
| +30% | +$196K | ﹤0.01% | 1106 |
|
|
2015
Q2 | $924K | Buy |
94,076
+79,473
| +544% | +$781K | ﹤0.01% | 1133 |
|
|
2015
Q1 | $129K | Hold |
14,603
| – | – | ﹤0.01% | 1857 |
|
|
2014
Q4 | $128K | Sell |
14,603
-14,602
| -50% | -$128K | ﹤0.01% | 1785 |
|
|
2014
Q3 | $201K | Hold |
29,205
| – | – | ﹤0.01% | 1632 |
|
|
2014
Q2 | $154K | Hold |
29,205
| – | – | ﹤0.01% | 1804 |
|
|
2014
Q1 | $133K | Hold |
29,205
| – | – | ﹤0.01% | 1858 |
|
|
2013
Q4 | $147K | Buy |
+29,205
| New | +$147K | ﹤0.01% | 1750 |
|